Zacks Investment Research cut shares of Landauer, Inc. (NYSE:LDR) from a buy rating to a hold rating in a research note issued to investors on Thursday.
According to Zacks, “Landauer Inc. is the world’s leading provider of analytical services to determine occupational and environmental radiation exposure. For more than fifty years, the company has provided complete radiation dosimetry services to hospitals, medical and dental offices, universities, national laboratories, and other industries in which radiation poses a potential threat to employees. Landauer’s services include the manufacture of various types of radiation detection monitors, the distribution and collection of the monitors to and from clients, and the analysis and reporting of exposure findings. The company provides its services to one.five million people in the United States, Japan, France, the United Kingdom, Brazil, Canada, China, Australia and other countries. “
Several other analysts have also recently weighed in on LDR. BidaskClub cut shares of Landauer from a sell rating to a strong sell rating in a research note on Tuesday, August 1st. Hilliard Lyons raised shares of Landauer from an underperform rating to a neutral rating in a research note on Wednesday.
Shares of Landauer (NYSE LDR) traded up 0.15% during trading on Thursday, reaching $68.10. The company’s stock had a trading volume of 198,511 shares. The stock has a market capitalization of $656.35 million, a price-to-earnings ratio of 35.27 and a beta of 1.27. The company’s 50-day moving average price is $59.69 and its 200 day moving average price is $53.58. Landauer has a 1-year low of $41.00 and a 1-year high of $68.40.
Landauer (NYSE:LDR) last issued its quarterly earnings data on Tuesday, August 8th. The scientific and technical instruments company reported $0.67 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.49 by $0.18. The firm had revenue of $39.89 million for the quarter. Landauer had a net margin of 12.09% and a return on equity of 80.03%. Analysts anticipate that Landauer will post $1.95 EPS for the current year.
TRADEMARK VIOLATION WARNING: This report was posted by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this report on another site, it was copied illegally and republished in violation of United States & international copyright and trademark law. The original version of this report can be viewed at https://sportsperspectives.com/2017/09/10/landauer-inc-ldr-downgraded-by-zacks-investment-research.html.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 3rd. Shareholders of record on Friday, September 15th will be paid a dividend of $0.275 per share. The ex-dividend date is Thursday, September 14th. This represents a $1.10 annualized dividend and a yield of 1.62%. Landauer’s dividend payout ratio is 56.99%.
A number of institutional investors have recently modified their holdings of the business. Vanguard Group Inc. grew its stake in Landauer by 2.2% during the second quarter. Vanguard Group Inc. now owns 867,506 shares of the scientific and technical instruments company’s stock worth $45,371,000 after buying an additional 18,733 shares during the last quarter. Bernzott Capital Advisors grew its stake in Landauer by 5.0% during the second quarter. Bernzott Capital Advisors now owns 447,156 shares of the scientific and technical instruments company’s stock worth $23,386,000 after buying an additional 21,250 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in Landauer by 8.7% during the second quarter. Dimensional Fund Advisors LP now owns 295,696 shares of the scientific and technical instruments company’s stock worth $15,465,000 after buying an additional 23,718 shares during the last quarter. Renaissance Technologies LLC grew its stake in Landauer by 11.6% during the first quarter. Renaissance Technologies LLC now owns 274,600 shares of the scientific and technical instruments company’s stock worth $13,387,000 after buying an additional 28,600 shares during the last quarter. Finally, Punch & Associates Investment Management Inc. grew its stake in Landauer by 1.9% during the second quarter. Punch & Associates Investment Management Inc. now owns 272,761 shares of the scientific and technical instruments company’s stock worth $14,265,000 after buying an additional 5,120 shares during the last quarter. 80.99% of the stock is currently owned by hedge funds and other institutional investors.
Landauer, Inc is a provider of technical and analytical services to determine occupational and environmental radiation exposure. The Company is a provider of outsourced medical physics services, and a provider of radiology related medical products. The Company operates through three segments: Radiation Measurement, Medical Physics and Medical Products.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Landauer Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Landauer Inc. and related companies with MarketBeat.com's FREE daily email newsletter.